On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Schedules Call, Will Release Q4 and FY 2020 Financial Results

Company: Trxade Group Inc. (MEDS)
Category: News

Trxade Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will report Q4 and FY 2020 financial results. MEDS will release the numbers, which are for the fourth quarter and fiscal year ended Dec. 31, 2020, after market close on March 29, 2021. As part of the reporting strategy, MEDS management will host a conference call. The call is scheduled for 5 p.m. ET on Monday, March 29, 2021. During the scheduled event, Trxade Group execs will discuss the company’s financial results and business highlights. The call will end with ample time for participants to ask MEDS team leaders clarifying and follow-up questions. Individuals interested in participating in the conference call or webcast can do so by dialing 1-877-425-9470 in the United States; international callers can dial 1-201-389-0878. Those who desire to call in are invited to call in at least 10 minutes early. In addition, a playback of the call can be accessed by phone — call 1-844-512-2921 inside the U.S. or 1-412-317-6671 when calling internationally and enter replay pin number 13716956 — or in the IR section of the company’s website.

To register for the webcast, visit https://nnw.fm/OU8lO

To view the full press release, visit https://nnw.fm/cX0pt

About Trxade Group Inc.

Trxade Group is a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving a total of 11,800-plus members nationwide and fostering price transparency as well as the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.networknewswire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217